{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:51:49Z","timestamp":1791435109471,"version":"4.3.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1124\/jpet.114.214262","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T06:27:06Z","timestamp":1399703226000},"page":"171-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Potent Inhibition of Alcohol Self-Administration in Alcohol-Preferring Rats by a \u03ba-Opioid Receptor Antagonist"],"prefix":"10.1016","volume":"350","author":[{"given":"John R.","family":"Cashman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.214262_bib1","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.114.214262_bib2","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.214262_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-8993(93)90309-B","article-title":"Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats","volume":"621","author":"Benjamin","year":"1993","journal-title":"Brain Res"},{"key":"10.1124\/jpet.114.214262_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-3057(97)00598-4","article-title":"Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats","volume":"60","author":"Biggs","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.114.214262_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"key":"10.1124\/jpet.114.214262_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13556210410001674130","article-title":"Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature","volume":"9","author":"Brewer","year":"2004","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.114.214262_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-291X(81)91881-7","article-title":"Microsomal oxidation of thiobenzamide. A photometric assay for the flavin-containing monooxygenase","volume":"98","author":"Cashman","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.114.214262_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archpsyc.1997.01830240090013","article-title":"The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study","volume":"54","author":"Croop","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.114.214262_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bcp.2003.10.022","article-title":"Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6","volume":"67","author":"Denton","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.114.214262_bib15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/jm701060e","article-title":"Synthesis and biological evaluation of \u03b1- and \u03b2-6-amido derivatives of 17-cyclopropylmethyl-3, 14\u03b2-dihydroxy-4, 5\u03b1-epoxymorphinan: potential alcohol-cessation agents","volume":"51","author":"Ghirmai","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.114.214262_bib16","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1016\/j.bmc.2009.07.069","article-title":"Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation","volume":"17","author":"Ghirmai","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.114.214262_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archpsyc.1996.01830030072011","article-title":"Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism","volume":"53","author":"Gianoulakis","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.114.214262_bib18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1530-0277.2008.00745.x","article-title":"Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats","volume":"32","author":"Gilpin","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/jpet.114.214262_bib19","first-page":"1699","article-title":"Decreased voluntary ethanol consumption in transgenic mice lacking \u03b2-endorphin (Abstract)","volume":"21","author":"Grisel","year":"1995","journal-title":"Soc Neurosci Abst."},{"key":"10.1124\/jpet.114.214262_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-9556(25)08004-3","article-title":"Microsomal metabolism of thiobenzamide and thiobenzamide S-oxide","volume":"11","author":"Hanzlik","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.114.214262_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0041-008X(80)90088-5","article-title":"Relative hepatotoxicity of substituted thiobenzamides and thiobenzamide-S-oxides in the rat","volume":"55","author":"Hanzlik","year":"1980","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.114.214262_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0041-008X(78)90313-7","article-title":"Substituent effects on the hepatotoxicity of thiobenzamide derivatives in the rat","volume":"46","author":"Hanzlik","year":"1978","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.114.214262_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050169","article-title":"Endogenous opioid systems and alcohol addiction","volume":"129","author":"Herz","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.214262_bib28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.214262_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3282f3cf70","article-title":"Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats","volume":"19","author":"Ji","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.114.214262_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.npp.1300338","article-title":"Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharin-reinforced behaviors in alcohol-preferring (P) rats","volume":"29","author":"June","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.214262_bib32","first-page":"2174","article-title":"The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats","volume":"22","author":"June","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/jpet.114.214262_bib33","first-page":"91","article-title":"Rodent lines selected for factors affecting alcohol consumption","volume":"1","author":"Li","year":"1987","journal-title":"Alcohol Alcohol Suppl"},{"key":"10.1124\/jpet.114.214262_bib35","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1021\/jm049554t","article-title":"Design, chemical synthesis, and biological evaluation of thiosaccharide analogues of morphine- and codeine-6-glucuronide","volume":"47","author":"MacDougall","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.114.214262_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","article-title":"A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence","volume":"56","author":"Mason","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.114.214262_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-3223(87)90127-2","article-title":"High-dose naltrexone therapy and dietary counseling for obesity","volume":"22","author":"Mitchell","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.114.214262_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2210-12-5","article-title":"Long-acting \u03ba opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity","volume":"12","author":"Munro","year":"2012","journal-title":"BMC Pharmacol"},{"key":"10.1124\/jpet.114.214262_bib40","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1248\/cpb.55.1489","article-title":"Catalytic aerobic oxidation of nor-binaltorphimine (nor-BNI) analogs without 4,5-epoxy bridge affords a more selective ligand for kappa opioid receptor than the representative kappa antagonist nor-BNI","volume":"55","author":"Osa","year":"2007","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/jpet.114.214262_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1369-1600.2006.00036.x","article-title":"Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone","volume":"11","author":"Oslin","year":"2006","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.114.214262_bib42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/sj.npp.1300928","article-title":"The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol","volume":"31","author":"Pastor","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.214262_bib43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.jcp.0000245566.52401.20","article-title":"The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking","volume":"26","author":"Pettinati","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.114.214262_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0741-8329(93)90091-2","article-title":"SDZ-205,152, a novel dopamine receptor agonist, reduces oral ethanol self-administration in rats","volume":"10","author":"Rassnick","year":"1993","journal-title":"Alcohol"},{"issue":"5, Suppl","key":"10.1124\/jpet.114.214262_bib45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/ajcn\/42.5.1099","article-title":"Endogenous opioid peptides and regulation of drinking and feeding","volume":"42","author":"Reid","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"10.1124\/jpet.114.214262_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euroneuro.2005.11.001","article-title":"A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence","volume":"16","author":"Roozen","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.114.214262_bib49","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/j.1552-4604.1994.tb04002.x","article-title":"Lack of hepatotoxicity with naltrexone treatment","volume":"34","author":"Sax","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.114.214262_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0741-8329(00)00137-3","article-title":"Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption","volume":"23","author":"Stromberg","year":"2001","journal-title":"Alcohol"},{"key":"10.1124\/jpet.114.214262_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0024-3205(83)90031-0","article-title":"Alcohol interactions with brain opiate receptors","volume":"32","author":"Tabakoff","year":"1983","journal-title":"Life Sci"},{"key":"10.1124\/jpet.114.214262_bib53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by \u03bc-opioid agonists of guanosine-5\u2032-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"Suppl 7","key":"10.1124\/jpet.114.214262_bib55","first-page":"5","article-title":"Opiates and alcohol self-administration in animals","volume":"56","author":"Ulm","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.114.214262_bib56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.npp.1301438","article-title":"Pharmacological evidence for a motivational role of \u03ba-opioid systems in ethanol dependence","volume":"33","author":"Walker","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.214262_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1369-1600.2010.00226.x","article-title":"Systemic \u03ba-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats","volume":"16","author":"Walker","year":"2011","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.114.214262_bib63","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1021\/jo800907e","article-title":"Carbonylation of aryl chlorides with oxygen nucleophiles at atmospheric pressure. Preparation of phenyl esters as acyl transfer agents and the direct preparation of alkyl esters and carboxylic acids","volume":"73","author":"Watson","year":"2008","journal-title":"J Org Chem"},{"key":"10.1124\/jpet.114.214262_bib58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrd1851","article-title":"Predicting in vivo drug interactions from in vitro drug discovery data","volume":"4","author":"Wienkers","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.214262_bib59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02244123","article-title":"Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide","volume":"101","author":"Weiss","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.214262_bib61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.alcohol.2006.05.003","article-title":"Study of hepatotoxicity of naltrexone in the treatment of alcoholism","volume":"38","author":"Yen","year":"2006","journal-title":"Alcohol"},{"key":"10.1124\/jpet.114.214262_bib62","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0149-7634(02)00041-6","article-title":"Opioid peptides and the control of human ingestive behaviour","volume":"26","author":"Yeomans","year":"2002","journal-title":"Neurosci Biobehav Rev"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524187149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524187149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.214262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:42:32Z","timestamp":1739986952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524187149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0022356524187149"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.214262","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent Inhibition of Alcohol Self-Administration in Alcohol-Preferring Rats by a \u03ba-Opioid Receptor Antagonist","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.214262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}